Some have relabeled it as Pentadecapeptide Aringate or PDA (changing the acetate to an arginate) and so are prescribing it for subcutaneous administration that way, although the confusion about its status has triggered a lively oral capsule market for BPC in what seems to get a grey space of legality.Clinicians are prescribing it via compounding ph… Read More